Katie Bunch examines how wearable healthcare devices collect sensitive health data that often falls outside of HIPAA protections. She explores potential gaps in federal and state privacy laws and argues for stronger consent requirements, expanded HIPAA coverage, and more uniform protections to ensure consumers’ health information is safeguarded as technology continues to advance.
Devin Scarborough examines the recent structural, regulatory, and political changes in the Food and Drug Administration brought on by the second term of the Trump administration. She argues that the Trump administration’s modifications have substantially weakened the FDA’s ability to protect the health of the American public by diminishing its ability to conduct sufficient research and implement necessary protections. She further analyzes the rising levels of foodborne illnesses that have coincided with FDA staffing cuts and decreases in food safety oversight, along with the increased risks associated with drug deregulation and political pressures within the agency. Ultimately, she concludes that the FDA’s institutional integrity and its ability to protect public health will continue to erode unless substantial corrective measures are taken.
In this article, Michelle L. Hampton analyzes a matter of first impression considering the extension of Title VI protections within federally funded healthcare facilities. This article is written in favor of the extended protections; however, with the recent overturning of several decades-long established precedents, this article acknowledges the possibility that the extension of such racial discriminatory protections may not be granted.
In this article, JT DeGrinney discusses the controversy surrounding Hims & Hers’s Super Bowl ad. He outlines compounded drugs’ regulatory background and considers arguments for considering the ad “misleading.”
In this article, Elias Aidun discusses the rapid advancements of AI in healthcare applications and the legal considerations that follow.
Jasmyn Hardin goes beyond the detrimental impacts that abortion restrictions have had on women’s health to examine the broader effects on the healthcare system and society at large. She argues that these policies are erecting new societal barriers while simultaneously exacerbating systemic failures, disproportionately worsening health disparities among groups that have historically faced societal oppression.
In this article, Cecilia Giles explores the Supreme Court’s subtle foreshadowing of future abortion access arguments in FDA v. Alliance of Hippocratic Medicine.
In this article, Madeline Brown discusses the alarming phenomenon of "ghost surgery," where a patient's chosen surgeon is replaced by another medical professional in the operating room. Patients may seek redress through lack of informed consent and battery claims, but exploration of additional patient protections is imperative to safeguard patients from this misleading practice.
Madeline Brown explores the horrifying practice of fertility fraud and its effects, alongside legislative efforts to protect victims and hold perpetrators accountable. Specifically, this article evaluates the strengths and weaknesses of two federal bills: the Protecting Families from Fertility Fraud Act and the Fighting Fertility Fraud Act.
Emotional support animals have grown in popularity in recent years, but sparse regulations on emotional support animal certification have left both healthcare providers and patients in a difficult spot. In this article, Associate Member Adam Drapcho argues for more structured guidance for emotional support animal certification.
